Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
Jun. 06 | Barclays Lifts Fresenius PT, Maintains Overweight Rating | MT |
Jun. 06 | FRESENIUS SE : Buy rating from Jefferies | ZD |
Sales 2024 * | 22.27B 23.98B | Sales 2025 * | 23.3B 25.09B | Capitalization | 16.99B 18.29B |
---|---|---|---|---|---|
Net income 2024 * | 1.38B 1.49B | Net income 2025 * | 1.73B 1.86B | EV / Sales 2024 * | 1.32 x |
Net Debt 2024 * | 12.45B 13.41B | Net Debt 2025 * | 11.74B 12.64B | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
12.3
x | P/E ratio 2025 * |
9.66
x | Employees | - |
Yield 2024 * |
3.13% | Yield 2025 * |
3.45% | Free-Float | 73.04% |
Latest transcript on Fresenius
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 21-04-11 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 18-12-31 |
Michael Moser
CMP | Compliance Officer | - | 23-07-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 15-05-19 |
Wolfgang Kirsch
CHM | Chairman | 69 | 19-12-31 |
Director/Board Member | 63 | 16-05-12 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 88.38B | |
-23.66% | 77.56B | |
+8.73% | 28.74B | |
-13.80% | 16.57B | |
+2.60% | 15.81B | |
+78.26% | 13.65B | |
+82.29% | 13.06B | |
+3.66% | 12.61B | |
+35.15% | 12.56B |
- Stock Market
- Equities
- FRE Stock
- 0OO9 Stock